Adagio Medical Holdings (ADGM) EBITDA Margin (2023 - 2024)
Adagio Medical Holdings (ADGM) posted EBITDA Margin of 3352.27% for Q3 2024, down 27.87% sequentially from 2621.65% in Q2 2024, and up 1879651.0% YoY from N/an in Q4 2023.
Adagio Medical Holdings (ADGM) EBITDA Margin (2023 - 2024) Analysis & Trends
Adagio Medical Holdings has reported EBITDA Margin for 2 years, with the latest figure at 3352.27% in Q3 2024.
- Quarterly EBITDA Margin rose 1879651.0% year-over-year to 3352.27% in Q3 2024, while the trailing twelve-month figure through Dec 2025 was 16517.42% (changed N/A YoY) and the FY2024 annual result came in at 23226.77%, down 1391277.0% from the prior year.
- EBITDA Margin fell to 3352.27% in Q3 2024 per ADGM's latest filing, from 2621.65% in the prior quarter.
- Over five years, EBITDA Margin peaked at 2621.65% in Q2 2024 and troughed at 33903.85% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 19.15% |
| 10 | Adagio Medical Holdings | 14.11 Mn | 14.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -3,352.27% |
| Jun 30, 2024 | -2,621.65% |
| Mar 31, 2024 | -33,903.85% |
| Dec 31, 2023 | -6,837.18% |
| Sep 30, 2023 | -22,148.78% |